Oncology Services Europe (OSE), a full service contract research organization (CRO), specialized in clinical drug development in oncology has launched its India operations in Ahmedabad, Gujarat.
Its new independent clinical services company Oncology Services India (OSI) will offer a complete clinical service range from Phase I (first-in-men) to Phase IV (PMS) trials.
Says CEO of OSI Vimal Sanghavi, "Clinical trials have grown increasingly global, larger and more complex. Government regulations are progressively more stringent, requiring more studies with larger patient populations especially in oncology."
"India is a favourable destination for conducting multinational clinical trials in the oncology segment. It offers us a large number of therapy-naive patients in various cancer entities, highly qualified and experienced investigators and hospitals."
Share this: 
Del.icio.us |
Email This | 
Printer Friendly
